|
|
||||||||
Viewpoint |
Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute–Frederick, National Institutes of Health, Frederick, MD 21702-1201
SUMMARY
Non-synonymous single nucleotide polymorphisms (SNPs) that result in amino acid sub-stitutions may have no appreciable effect on protein function, but those that involve critical residues may cause or contribute to disease. Large-scale gene sequencing studies have revealed a daunting number of non-synonymous SNPs with unknown functional consequences. Both predictive techniques and functional assays can aid in the identification of disease-relevant SNPs, as illustrated by two recent reports. An insightful comparison of known disease-causing vs uncharacterized SNPs in protein kinases sheds new light on regions of the catalytic core. The observed prevelance of disease-causing SNPs in substrate binding and regulatory regions––but paucity thereof in residues directly involved in the catalytic reaction––will likely extend to other enzymes as well. A clever functional bioassay using mouse ES cells distinguishes neutral from deleterious mutations in the breast and ovarian cancer-related BRCA2 gene, which may aid in the interpretation of patient BRCA2 screening data.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |